Tag: Pounce Thrombectomy

Endologix Acquires Pounce™ Thrombectomy System, Expanding Its Vascular Intervention Portfolio

Financial Peripheral/Endo by 0 comments

SANTA ROSA, Calif.–(BUSINESS WIRE)–Endologix LLC, a privately held, global medical device company focused on advancing innovative therapies for the interventional treatment of vascular disease, today announced the acquisition of the Pounce™ Thrombectomy System from Surmodics, Inc. The transaction closed on May 18, 2026. The Pounce System is an FDA-cleared, fully mechanical thrombectomy system for the non-surgical removal of thrombi and emboli from peripheral arteries. Built around proprietary

Continue Reading →

Pounce™ Thrombectomy System First-in-Human Data Show 100 Percent Technical Success in Early Cases

Peripheral/Endo by 0 comments

Thrombolytics in target lesion were not used for 19 of 20 patients treated with next-generation mechanical arterial thrombectomy device EDEN PRAIRIE, Minn.–(BUSINESS WIRE)–Surmodics, Inc. (NASDAQ : SRDX), a leading provider of medical device and in vitro diagnostic technologies to the health care industry, announced today that its Pounce™ Thrombectomy System […]

Continue Reading →